Concepedia

Kazuyoshi Tenjinbaru

KT

Statistics

Publications

5

Citations

83

H-Index

5

Active since

1999

Affiliations

Haradoi Hospital(Current)

GlaxoSmithKline (Japan)

GlaxoSmithKline (Belgium)

GlaxoSmithKline (Netherlands)

Tokyo National Hospital

Kazuyoshi Tenjinbaru is an author at Haradoi Hospital specializing in vaccine immunology, vaccine safety, and vaccination.

Publications per year

1999–2012

5

Publications

5

Nuclear translocation of green fluorescent protein‐nuclear factor κB with a distinct lag time in living cells

Kazuyoshi Tenjinbaru, Tadahide Furuno, Naohide Hirashima et al. · FEBS Letters · 1999 · 25 citations

, , +14

Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan

Hideyuki Ikematsu, Hideaki Nagai, Masahiro Kawashima et al. · Human Vaccines · 2010 · 21 citations · Full text

, , +17

A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults

Hideaki Nagai, Hideyuki Ikematsu, Kazuyoshi Tenjinbaru et al. · BMC Infectious Diseases · 2010 · 14 citations · Full text

, , +17

Evaluation of immune response following one dose of an AS03 <sub>A</sub> -adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Hideyuki Ikematsu, Kazuyoshi Tenjinbaru, Ping Li et al. · Human Vaccines & Immunotherapeutics · 2012 · 12 citations · Full text

, , +17

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

Hideyuki Ikematsu, Hideaki Nagai, Masahiro Kawashima et al. · Human Vaccines & Immunotherapeutics · 2012 · 11 citations · Full text

, , +17

1–5 of 5